PDL (PDLI) To Pay $92.5M in Settlement with MedImmune
Tweet Send to a Friend
PDL BioPharma, Inc. (Nasdaq: PDLI) has entered into a settlement with MedImmune, LLC.
This article: 64 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 64 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
